{"id":137764,"date":"2024-10-29T16:06:24","date_gmt":"2024-10-29T10:36:24","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=137764"},"modified":"2024-10-29T16:12:54","modified_gmt":"2024-10-29T10:42:54","slug":"smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/","title":{"rendered":"Smallcap stock jumps 8% after reporting 93% YoY increase in net profits\u00a0"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1202543908\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Small-cap pharma stock, involved in the engaged in manufacturing and export of active pharmaceutical ingredients, surged 8.5 percent following a 93.22 percent year-on-year growth in net profit for Q2 FY25.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-680226635\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Share price variations:&nbsp;<\/strong><\/h2><p>With a market capitalization of Rs. 4,767.00 crores, <strong>Supriya Lifescience Ltd<\/strong>. rose to an intraday high of Rs. 601.65 representing an 8.5 percent increase from its previous closing price of Rs. 554.35 per share.\u00a0<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Reason for the Rise:&nbsp;<\/strong><\/h2><p>According to exchange filings, <strong>Supriya Lifescience Ltd <\/strong>reported a 93.22 percent year-on-year increase in net profit for Q2 FY25, reaching Rs 46.14 crore, up from Rs 23.88 crore in Q2 FY24. On a quarter-on-quarter basis, net profit surged by 3.3 percent, rising from Rs. 44.64 crore in Q1 FY25.&nbsp;<\/p><p>Revenue grew by 18.27 percent year-on-year to Rs. 168.62 crore, compared to Rs. 142.56 crore in the same period last year. Sequentially, revenue increased by 3.5 percent from Rs. 162.85 crore in Q1 FY25.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-2390539188\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>The business mix revenue contribution is led by the Analgesic and Anesthetic segments at 54.9 percent, followed by Vitamins at 11.6 percent, Anti-histamines at 9.3 percent, Anti-Asthmatic at 9.2 percent, Anti-allergic at 5.2 percent, and Anti-hypertensive at 1.8 percent.&nbsp;<\/p><p>For the first half of FY25, revenue rose by 19.44 percent to Rs. 331.47 crores, up from Rs. 277.5 crores in H1 FY24, while net profit increased by 73.28 percent, reaching Rs. 90.79 crores compared to Rs. 52.39 crores in the previous year.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the company:&nbsp;<\/strong><\/h2><p>Incorporated in 2008, Supriya Lifescience Ltd is engaged in the manufacturing and export of active pharmaceutical ingredients(APIs). As of October the company has a product basket of 32 APIs and is the largest exporter of chlorpheniramine maleate, ketamine hydrochloride, and salbutamol sulphate from India.&nbsp;<\/p><p>In FY24, exports contributed approximately 79% of the company\u2019s revenue, with the top 10 clients accounting for 49% of total revenue. The company operates four manufacturing blocks over a 23,806 sq. mt area, with a reactor capacity of 597 KL per day.\u00a0<\/p><p>Region-wise, revenue distribution for Q2FY25 is 45% from Europe, 32% from Asia, 14% from Latin America and the Caribbean, 4% from North America, and 5% from other regions, serving a customer base of over 1,700 across 86 countries.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written By&nbsp;Joseph Pv&nbsp;<\/strong><\/p><\/blockquote><h2 class=\"wp-block-heading has-medium-font-size\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h2><div class=\"wp-block-image\"><figure class=\"aligncenter\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on&nbsp;<a href=\"https:\/\/tradebrains.in\/\">tradebrains.in<\/a>&nbsp;are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-content-10\" id=\"trade-174055807\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-948079263\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Small-cap pharma stock, involved in the engaged in manufacturing and export of active pharmaceutical ingredients, surged 8.5 percent following a 93.22 percent year-on-year growth in net profit for Q2 FY25.&nbsp; Share price variations:&nbsp; With a market capitalization of Rs. 4,767.00 crores, Supriya Lifescience Ltd. rose to an intraday high of Rs. 601.65 representing an 8.5 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":49884,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[15654,948,936,20972,24095,24096],"class_list":["post-137764","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-pharma-stock-news","tag-stock-market","tag-stock-market-news","tag-supriya-lifescience","tag-supriya-lifescience-latest-profits","tag-supriya-lifescience-quarter-results"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Smallcap stock jumps 8% after reporting 93% YoY increase in net profits\u00a0 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Small-cap pharma stock, involved in the engaged in manufacturing and export of active pharmaceutical ingredients, surged 8.5 percent following a 93.22 percent year-on-year growth in net profit for Q2 FY25.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Smallcap stock jumps 8% after reporting 93% YoY increase in net profits\u00a0\" \/>\n<meta property=\"og:description\" content=\"Small-cap pharma stock, involved in the engaged in manufacturing and export of active pharmaceutical ingredients, surged 8.5 percent following a 93.22 percent year-on-year growth in net profit for Q2 FY25.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-29T10:36:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-29T10:42:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/\",\"url\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/\",\"name\":\"Smallcap stock jumps 8% after reporting 93% YoY increase in net profits\u00a0 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\",\"datePublished\":\"2024-10-29T10:36:24+00:00\",\"dateModified\":\"2024-10-29T10:42:54+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Small-cap pharma stock, involved in the engaged in manufacturing and export of active pharmaceutical ingredients, surged 8.5 percent following a 93.22 percent year-on-year growth in net profit for Q2 FY25.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Smallcap stock jumps 8% after reporting 93% YoY increase in net profits\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Smallcap stock jumps 8% after reporting 93% YoY increase in net profits\u00a0 - Trade Brains Features","description":"Small-cap pharma stock, involved in the engaged in manufacturing and export of active pharmaceutical ingredients, surged 8.5 percent following a 93.22 percent year-on-year growth in net profit for Q2 FY25.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/","og_locale":"en_US","og_type":"article","og_title":"Smallcap stock jumps 8% after reporting 93% YoY increase in net profits\u00a0","og_description":"Small-cap pharma stock, involved in the engaged in manufacturing and export of active pharmaceutical ingredients, surged 8.5 percent following a 93.22 percent year-on-year growth in net profit for Q2 FY25.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-10-29T10:36:24+00:00","article_modified_time":"2024-10-29T10:42:54+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/","url":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/","name":"Smallcap stock jumps 8% after reporting 93% YoY increase in net profits\u00a0 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","datePublished":"2024-10-29T10:36:24+00:00","dateModified":"2024-10-29T10:42:54+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Small-cap pharma stock, involved in the engaged in manufacturing and export of active pharmaceutical ingredients, surged 8.5 percent following a 93.22 percent year-on-year growth in net profit for Q2 FY25.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/06\/Pharma-1-Cover-Image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/smallcap-stock-jumps-8-after-reporting-93-yoy-increase-in-net-profits\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Smallcap stock jumps 8% after reporting 93% YoY increase in net profits\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/137764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=137764"}],"version-history":[{"count":4,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/137764\/revisions"}],"predecessor-version":[{"id":137771,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/137764\/revisions\/137771"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/49884"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=137764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=137764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=137764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}